Characteristics and Applications of Bioactive Peptides in Skin Care |
Moh, Sang-Hyun
(Anti-aging Research Institute of BIO-FD&C Co., Ltd.)
Jung, Dai-Hyun (Anti-aging Research Institute of BIO-FD&C Co., Ltd.) Kim, Hyoung-Shik (Anti-aging Research Institute of BIO-FD&C Co., Ltd.) Cho, Moon-Jin (Anti-aging Research Institute of BIO-FD&C Co., Ltd.) Seo, Hyo-Hyun (Anti-aging Research Institute of BIO-FD&C Co., Ltd.) Kim, Sung-Jun (Graduate School of Social Education, Sookmyung Women's University) |
1 | Mary, P. L. and A. L. Cole (2007) Cosmeceutical peptides. Dermatol. Ther. 20: 343-349. DOI ScienceOn |
2 | Vlieghe, P., V. Lisowski, J. Martinez, and M. Khrestchatisky (2010) Synthetic therapeutic peptides: science and market. Drug Discovery Today 15: 41-56. |
3 | Lee, S. K. (1997) Development of recombinant human growth hormone in yeast: efficacy evaluation and safety assessment. Proceedings of the Korean Society of Toxicology Conference. October. Korea. |
4 | Zhang, L. and T. J. Falla (2009) Cosmeceuticals and peptides. Clinics in Dermatology 27: 485-494. DOI ScienceOn |
5 | Fields, K., T. J. Falla, K. Rodan, and L. Bush (2009) Bioactive peptides: signaling the future. J. Cosmetic Dermatology 8: 8-13. DOI ScienceOn |
6 | Samah, N. H. A. and C. M. Heard (2011) Topically applied KTTKS: a review. J. Cosmet. Sci. 33: 483-490. DOI ScienceOn |
7 | Dellai, A., I. Maricic, V. Kumar, S. Arutyunyan, A. Bouraoui, and A. Nefzi (2010) Parallel synthesis and anti-inflammatory activity of cyclic peptides cyclosquamosin D and Met-cherimolacyclopeptide B and their analogs. Bio. Med. Chem. Lett. 20: 5653-5657. DOI ScienceOn |
8 | Metaferia, B. B., M. Rittler, J. S. Gheeya, A. Lee, H. Hempel, A. Plaza, W. G. S. Stevenson, C. A. Bewley, and J. Khan (2010) Synthesis of novel cyclic NGR/RGD peptide analogs via on resin click chemistry. Bio. Med. Chem. Lett. 20: 7337-7340. DOI ScienceOn |
9 | Richter, S., T. Ramenda, R. Bergmann, T. Kniess, J. Steinbach, J. Pietzsch, and F. Wuest (2010) Synthesis of neurotensin(8-13)-phosphopeptide heterodimers via click chemistry. Bio. Med. Chem. Lett. 20: 3306-3309. DOI ScienceOn |
10 | Grillo, B., D. F. Rabanal, and E. Giralt (2011) Improved Fmoc based solid phase synthesis of homologous peptide fragments of human and mouse prion proteins. J. Peptide Science 17: 32-38. DOI ScienceOn |
11 | Coin, I., M. Beyermann, and M. Bienert (2007) Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences. Nature Protocols 2: 3247-3256. DOI ScienceOn |
12 | Chiara, F., L. Luisa, P. Alessandro, and B. Luisa (2005) Bioactive Peptides from Libraries. Chemistry biology 12: 417-426. DOI ScienceOn |
13 | Valerie, D., N. Pierrick, M. Jean, and L. Frederic (2009) Solventfree synthesis of peptides. Angewandte Chemie 121: 9482-9485. DOI ScienceOn |
14 | Andrey I., L. Liran, M. Amram, A. C. Gregory, F. D. William, M. Mati, L. Binhua, and G. David (2010) Role of the conformational rigidity in the design of biomimetic antimicrobial compounds. Angewandte Chemie 49: 8460-8463. |
15 | Hartmann, R. and H. Meisel (2007) Food-derived peptides with biological activity: from research to food applications. Cur. Opin. Bio. 18: 163-169. DOI ScienceOn |
16 | Sato, A. K., M. Viswanathan, R. B. Kent, and C. R. Wood (2006) Therapeutic peptides: technological advances driving peptides into development. Current opinion in biotech. 17: 638-642. DOI ScienceOn |
17 | Ioannis, S., F. Demosthenes, V. Katerina, G. T. Andreas, K. Valentinos and B. Evangelos (2010) Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs. Mar. Drugs 8: 629-657. DOI |
18 | Osborne, R., L. A. Mullins, and B. B. Jarrold (2009) Understanding metabolic pathways for skin anti-aging. J. Drugs Der. 8: 4-7. |
19 | Ruiz, M. A., B. Clares, M. E. Morales, and V. Gallardo (2010) Evaluation of the anti-wrinkle efficacy of cosmetic formulations with an anti-aging peptide (). Ars. Pharm. 50: 168-176. |
20 | Benedetto, A. V. (1998) Environment and skin aging. Clin. Derm. 16: 129-139. DOI ScienceOn |
21 | Amer, M. and M. Maged (2009) Cosmeceuticals versus pharmaceuticals. Clinics in dermatology 27: 428-430. DOI ScienceOn |
22 | Bissett, D. L. (2009) Common cosmeceuticals. Clinics in dermatology 27: 435-445. DOI ScienceOn |
23 | Foldvari, M., S. Attah-Poku, J. Hu, Q. Li, H. Hughes, L. A Babiuk, and S. Kruger (1998) Palmitoyl derivatives of interferon: potential for cutaneous delivery. J. Pharmaceutical Sciences 87: 1203-1208. DOI |
24 | Robinson, L. R., N. C. Fitzgerald, D. G. Doughty, N. C. Dawes, C. A. Berge, and D. L. Bissett (2005) Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. J. Cosmetic science 27: 155-160. DOI ScienceOn |
25 | Lee, H. J. (2011) The use of oligopeptides as cosmetics and pharmaceuticals. Foreign high-tech research business report, pp. 9. Korean Institute of Science and Technology Information Press, Seoul. |
26 | Becker-Wegerich, P. M., L. Rauch, and T. Ruzicka (2002) Botulinum toxin A: successful decollete rejuvenation. Dermatologic Surgery 28: 168-171. DOI ScienceOn |
27 | Goldsmith, J., L. Granera, and C. Wolfe (2009) Effects of argireline on EPSP amplitude at the crayfish neuromuscular junction. Pioneering Neuroscience 10: 11-14. |
28 | Furstenau, A., G. Hazeltine, and M. Miller (2010) The effectiveness of argireline as a synthetic BoNT questioned, as examined in the neuromuscular junction of the procambarus clarkii. Pioneering Neuroscience 7: 7-10. |
29 | Blanes, M., C. J. Clemente, G. Jodas, A. Gil, G. F. Ballester, B. Ponsati, L. Gutierrez, E. P. Paya, and A. F. Montiel (2002) A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int. J. Cos. Sci. 24: 303-310. DOI ScienceOn |
30 | Gutierrez, L. M., S. Viniegra, J. Rueda, A. V. Ferrer-Montiel, J. M. Canaves, and M. Montal (1997) A peptide that mimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chromaffin cells. J. Bio. Chem. 272: 2634-2639. DOI |
31 | Antonio, V. F., M. G. Luis, P. A. James, M. C. Jaume, G. Anabel, V. Salvador, A. B. Jennifer, A. Michael, and M. Mauricio (1998) The 26-mer peptide released from SNAP-25 cleavage by botulinum neurotoxin E inhibits vesicle docking. FEBS Lett. 435: 84-88. DOI ScienceOn |
32 | Luis, M. G., M. C. Jaume, V. F. Antonio, A. R. Juan, M. Mauricio, and V. Salvador (1995) A peptide that mimics the carboxyterminal domain of SNAP-25 blocks Ca2+-dependent exocytosis in chromaffin cells. FEBS Lett. 372: 39-43. DOI ScienceOn |
33 | Maquar, F. X., L. Pickartb, M. Laurentc, P. Gillerya, J. C. Monboissea, and J. P. Borela (1988) Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 238: 343-346. DOI ScienceOn |
34 | Gorouhi, F. and H. I. Maibach (2009) Role of topical peptides in preventing or treating aged skin. J. Cosmetic Science 31: 327-345. DOI ScienceOn |
35 | Yamamoto, I., N. Muto, K. I. Murakami, and J. I. Akiyama (1992) Collagen synthesis in human skin fibroblasts is stimulated by a stable form of ascorbate, 2-O--D-Glucopyranosyl-L-Ascorbic acid. J. Nutr. 122: 871-877. |
36 | Wegrowski, Y., F. X. Maquart, and J. P. Borel (1992) Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex Glycyl-L-histidyl-L-lysine-Cu2+. Life Sciences 51: 1049-1056. DOI ScienceOn |
37 | Pickart, L. (2008) The human tri-peptide GHK and tissue remodeling. J. Bio. Sci. 19: 969-988. DOI ScienceOn |
38 | Lampe, J. W. and J. L. Chang (2007) Interindividual differences in phytochemical metabolism and disposition. Seminars in Cancer Biology 17: 347-353. DOI ScienceOn |
39 | Chen, J. H. and C. T. Ho (1997) Antioxidant activities of caffeic acid and Its related hydroxycinnamic acid compounds. J. Agric. Food Chem. 45: 2374-2378. DOI ScienceOn |
40 | Krizkova, L., M. Nagy, J. Polonyi, J. Dobias, A. Belicova, D. Grancai, and J. Krajcovic (2000) Phenolic acids inhibit chloroplast mutagenesis in euglena gracilis. Mutat. Res. 469: 107-114. DOI ScienceOn |
41 | Shahrzad, S., K. Aoyagi, A. Winter, A. Koyama, and I. Bitsch (2001) Research communication: pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J. Nutrition 131: 1207-1210. |
42 | Kroes, B. H., A. J. J. Berg, H. C. Q. Ufford, H. Dijk, and R. P. Labadie (1992) Anti-inflammatory activity of gallic acid. Planta. Med. 58: 499-504. DOI ScienceOn |
43 | Kang, N. J., K. W. Lee, B. J. Shin, S. K. Jung, M. K. Hwang, A. M. Bode, Y. S. Heo, H. J. Lee, and Z. Dong (2009) Caffeic acid, a phenolic phytochemical in coffee, directly inhibits fyn kinase activity and UVB-induced COX-2 expression. Carcinogenesis 30: 321-330. |
44 | Jung, U. J., M. K. Lee, Y. B. Park, S. M. Jeon, and M. S. Choi (2006) Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. J. Pharm. Exp. Ther. 318: 476-483. DOI ScienceOn |
45 | Ow, Y. Y. and I. Stupans (2003) Gallic acid and gallic acid derivatives: effects on drug metabolizing enzymes. Current Drug Metabolism 4: 241-248. DOI ScienceOn |
46 | Kubo, I., Q. X. Chen, and K. Nihei (2003) Molecular design of antibrowning agents: antioxidative tyrosinase inhibitors. Food Chemistry 81: 241-247. DOI ScienceOn |
47 | Kubo, I., I. Kinst-Hori, Y. Kubo, Y. Yamagiwa, T. Kamikawa, and H. Haraguchi (2000) Molecular design of antibrowning agents. J. Agric. Food Chem. 48: 1393-1399. DOI ScienceOn |
48 | Kim, Y. J. (2007) Antimelanogenic and antioxidant properties of gallic acid. Biol. Pharm. Bull. 30: 1052-1055. DOI ScienceOn |
49 | Kim, S. H., C. D. Jun, K. H. Suk, B. J. Choi, H. J. Lim, S. J. Park, S. H. Lee, H. Y. Shin, D. K. Kim, and T. Y. Shin (2006) Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicological Sciences 91: 123-131. DOI ScienceOn |
50 | Chen, L. G., W. L. Chang, C. J. Lee, and L. T. Lee (2009) Melanogenesis inhibition by gallotannins from chinese galls in B16 mouse melanoma cells. Biol. Pharm. Bull. 32: 1447-1452. DOI ScienceOn |
51 | Gehring, W. (2004) Nicotinic acid/niacinamide and the skin. J. Cos. Der. 3: 88-93. |
52 | Loren, P. (2002) Copper peptides for tissue regeneration. Speciality Chemicals 22: 29-31. |
53 | Ferruti, P. and R. Paoletti (1978) High polymers containing nicotinic acid, process for their preparation and their use. US Patent 4,067,876. |
54 | Hakozaki, T., L. Minwalla, J. Zhuang, M. Chhoa, A. Matsubara, K. Miyamoto, A. Greatens, G. G. Hillebrand, D. L. Bissett, and R. E. Boissy (2002) The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Bri. J. Der. 147: 20-31. |
55 | Nico, S., V. Jana, and P. Stan (2009) The hunt for natural skin whitening agents. Int. J. Mol. Sci. 10: 5326-5349. DOI ScienceOn |
56 | Boonme, P., V. Junyaprasert, B. Varaporn, N. Suksawad, and S. Songkro (2009) Microemulsions and nanoemulsions: novel vehicles for whitening cosmeceuticals. J. Biomedical Nanotechnology 5: 373-383. DOI ScienceOn |
57 | Shen, B., D. M. Makley, and J. N. Johnston (2010) Umpolung' reactivity in semiaqueous amide and peptide synthesis. Nature 465: 1027-1032. DOI ScienceOn |
58 | Youhei, S. and K. Yoshiaki (2006) Click peptides-chemical biology-oriented synthesis of alzheimer's disease-related amyloid peptide (A) analogues based on the o-acyl isopeptide method. Chem. Bio. Chem. 7: 1549-1557. DOI ScienceOn |
59 | Han, S. Y. and Y. A. Kim (2004) Recent development of peptide coupling reagents in organic synthesis. Tetrahedron 60: 2447-2467. DOI ScienceOn |
60 | Grillo-Bosch, D., F. Rabanal, and E. Giralt (2011) Improved Fmoc based solid phase synthesis of homologous peptide fragments of human and mouse prion proteins. J. Peptide Science 17: 1075-2617. |
61 | Sarika, N. and A. E. B. Heather (2010) Cyclic peptides as potential therapeutic agents for skin disorders. Peptide Science 94: 673-680. DOI ScienceOn |
62 | Matsuzaki, K. (2009) Control of cell selectivity of antimicrobial peptides. BBA 1788: 1687-1692. DOI ScienceOn |